Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.13
|
1.18
|
1.08
|
1.05
|
1.20
|
1.1796
|
|
|
13 027.93
|
100.00
|
1.07
|
1.14
|
1.11
|
1.05
|
1.11
|
1.07
|
|
|
27 283.11
|
137.00
|
1.03
|
1.09
|
1.04
|
1.03
|
1.11
|
1.10
|
|
|
9 507.27
|
57.00
|
0.97
|
1.07
|
1.06
|
1.03
|
1.07
|
1.04
|
|
|
7 172.83
|
65.00
|
1.03
|
1.18
|
1.16
|
1.01
|
1.16
|
1.03
|
|
|
50 744.92
|
221.00
|
1.05
|
1.15
|
1.06
|
1.05
|
1.11
|
1.11
|
|
|
25 993.82
|
150.00
|
1.00
|
1.04
|
1.05
|
0.9801
|
1.08
|
1.01
|
|
|
18 791.98
|
106.00
|
0.99
|
1.13
|
1.05
|
1.02
|
1.10
|
1.07
|
|
|
42 434.58
|
214.00
|
1.02
|
1.13
|
1.10
|
1.01
|
1.14
|
1.05
|
|
|
81 723.61
|
500.00
|
1.10
|
1.19
|
1.15
|
1.08
|
1.16
|
1.09
|
|
|
16 241.37
|
140.00
|
Xilio Therapeutics, Inc. operates as a biotech company. The Company focuses on developing tumor-targeted immuno-oncology therapeutics. Xilio Therapeutics serves medical sector in the United States.